MALARIA, FALCIPARUM
Clinical trials for MALARIA, FALCIPARUM explained in plain language.
Never miss a new study
Get alerted when new MALARIA, FALCIPARUM trials appear
Sign up with your email to follow new studies for MALARIA, FALCIPARUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria pill shows promise in early trial
Disease control Not yet recruitingThis study tests a new oral drug, GSK3772701, for adults with uncomplicated malaria caused by the P. falciparum parasite. About 70 participants will receive different doses and treatment durations to check safety and how the drug works in the body. The goal is to find a well-tole…
Matched conditions: MALARIA, FALCIPARUM
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
New malaria shot could offer months of protection
Prevention Not yet recruitingThis early-stage study tests a single injection of MMV371, a long-acting medicine, to see if it safely prevents malaria in healthy adults and teens aged 12-50 in Rwanda. About 80 participants will get either the study drug or a placebo, and researchers will monitor them for 24 we…
Matched conditions: MALARIA, FALCIPARUM
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated May 17, 2026 07:03 UTC
-
New combo strategy aims to slash malaria in ugandan kids
Prevention Not yet recruitingThis study tests whether giving children the R21 malaria vaccine along with two new drug regimens can prevent malaria better than the vaccine alone. About 1,290 children in rural Uganda will take part. The goal is to find a stronger way to protect kids from this life-threatening …
Matched conditions: MALARIA, FALCIPARUM
Phase: PHASE4 • Sponsor: Stanford University • Aim: Prevention
Last updated May 15, 2026 11:54 UTC